Shanghai, China – March 20-22, 2024 – The 2024 China International Exhibition for Personal Care and Home Ingredients (PCHi2024), a three-day event held at the Shanghai World Expo Exhibition & Convention Center, concluded on a high note.

 

Stunning appearance at PCHi2024, Focusfreda’ s innovative products and R&D achievements were praised by the audience

As a globally renowned operator specializing in sodium hyaluronate products, Focusfreda showcased a plethora of best-selling cosmetic-grade raw materials at the exhibition. The company attracted numerous clients and industry professionals who were eager to learn more about their offerings. Additionally, Focusfreda attended the Freda Group+PCHi 2024 “Keeping Integrity and Innovation, ‘Core’ Generates the Future” theme forum and delivered a speech to share the current status and latest progress of hyaluronic acid research. Standing on the world stage, China’s sodium hyaluronate products received widespread acclaim.

 

With China emerging as a central player in the global market, PCHi serves as a significant platform for domestic and international raw material suppliers to engage with manufacturers of cosmetics, personal care, and household products. The annual event, held in the Yangtze River Delta and Pearl River Delta regions, coincides with the regional hubs of production for personal care, cosmetics, toiletries, and household care industries.

 

Focusfreda contributes to the development of new productivity in the industry

During the exhibition, Focusfreda’s booth attracted significant attention, with their cosmetic-grade Tremella fuciformis polysaccharide, acetylated sodium hyaluronate, sodium hyaluronate fermentation broth, and 8-fold hyaluronic acid solution garnering interest from attendees. The company’s technical and sales teams engaged with visitors, facilitating discussions on potential collaborations, market insights, and industry trends. Their efforts were met with appreciation and recognition from a diverse array of clients and industry stakeholders, underscoring Focusfreda’s commitment to advancing technological innovation within the industry.

 

On the morning of March 20, at the “Keeping Integrity and Innovation, ‘Core’ Generates the Future” forum, Chuanli Kang, deputy general manager of Focusfreda, delivered a keynote speech titled “Construction of Hyaluronidase Strain and Application in Oligosaccharide Preparation“. Mr. Kang discussed the prospects and research status of hyaluronidase, as well as its application in oligosaccharide preparation, with experts, scholars, and industry leaders.

Focusfreda is driven by technology and leads the innovation of hyaluronic acid oligosaccharides

At present, Focusfreda has mastered advanced enzyme digestion technology, and its “hyaluronidase and hyaluronic acid oligosaccharide biomanufacturing technology” has been recognized as “internationally advanced level” by the China Private Technology Enterprises Association. The company has won a number of core patents and technology awards at home and abroad, and was the first to launch a series of hyaluronic acid oligosaccharide products such as Hyaoligo® Sodium Hyaluronate and Rejuv-800 Dalton. Focusfreda’s outstanding performance at PCHi once again highlights its leading R&D capabilities and cutting-edge product supply. Looking forward to the future, Freda Group will continue to be committed to using high-tech research and modern manufacturing processes to provide customers with innovative products and top technical solutions and promote high-quality development of the industry.

         

For media inquiries, please contact:

86+0537-3195566

sales@focuschem.com

https://www.focus-freda.com/

Shandong Focusfreda Biotech Co,.Ltd.